Law360, New York (November 25, 2009, 5:37 PM EST) -- Sunrise Pharmaceutical Inc. and three other consolidated defendants have been dismissed from a lawsuit that is trying to stop them from selling gout treatments with the active ingredient colchicine, though it appears they will face claims in another jurisdiction.
On Tuesday, Judge Garrett E. Brown Jr. of the U.S. District Court for the District of New Jersey approved the dismissal of Sunrise without prejudice. About a month earlier, the judge similarly dismissed Indena SpA, Indena USA Inc. and Alchem International Ltd. without prejudice.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.